Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Radius Recycling, Inc. - Class A Common Stock (NQ:RDUS)

28.71 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Radius Recycling, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
Mid-Morning Market Update: Markets Mixed; United Natural Foods Beats Q1 Views
Following the market opening Wednesday, the Dow traded up 0.10% to 35,754.05 while the NASDAQ fell 0.09% to 15,672.72. The S&P also rose, gaining 0.06% to 4,689.49. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Radius Health Stock Stares At 52-Week Low After Disappointing Abaloparatide Transdermal Data In Osteoporosis
Radius Health Inc (NASDAQ: RDUS) posted topline data from Phase 3 wearABLe study evaluating the non-inferiority (NI) of abaloparatide transdermal system (abalo-TDS... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Radius Health
Over the past 3 months, 5 analysts have published their opinion on Radius Health (NASDAQ: 
Via Benzinga
Radius Health (RDUS) Q3 2021 Earnings Call Transcript
RDUS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Outlook For Radius Health
Radius Health (NASDAQ:RDUS) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Analyst Ratings For Radius Health
Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Turns Lower; Sesen Bio Shares Surge
Toward the end of trading Wednesday, the Dow traded up 0.46% to 35,619.52 while the NASDAQ fell 0.19% to 15,100.51. The S&P also rose, gaining 0.28% to 4,532.23. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Sesen Bio (NASDAQ:SESN) stock increased by 29.2% to $1.3 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 149.3 million... 
Via Benzinga
Mid-Day Market Update: Healthcare Services Drops After Q3 Results; Radius Health Shares Jump
Midway through trading Wednesday, the Dow traded up 0.40% to 35,598.89 while the NASDAQ rose 0.15% to 15,151.71. The S&P also rose, gaining 0.37% to 4,536.47. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Radius Health Stock Is Exploding Higher Today
Positive clinical-trial results for a late-stage breast cancer treatment are pushing the stock up. 
Via The Motley Fool
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... 
Via Benzinga
Exposures Product Safety
Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded up 0.35% to 35,580.21 while the NASDAQ rose 0.11% to 15,146.02. The S&P also rose, gaining 0.32% to 4,533.97. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Are Radius Health Shares Soaring Today?
The Menarini Group and Radius Health Inc (NASDAQ: RDUS) have announced topline results from the EMERALD Phase 3 study evaluating elacestrant as... 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
Radius Health Earnings Perspective: Return On Capital Employed
According to Benzinga Pro data, during Q2, Radius Health (NASDAQ:RDUS) posted sales of $51.80 million. Earnings were up 11.28%, but Radius Health still reported an overall loss of... 
Via Benzinga
Radius Health (RDUS) Q2 2021 Earnings Call Transcript
RDUS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. 
Via Talk Markets
Exposures Product Safety
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal... 
Via Benzinga
Exposures Product Safety
Radius Health (RDUS) Q1 2021 Earnings Call Transcript
RDUS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Radius Health's Earnings: A Preview
Radius Health (NASDAQ:RDUS) announces its next round of earnings this Friday, May 07. Here is Benzinga's everything-that-matters guide for this Friday's Q1 earnings announcement... 
Via Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.